New Patent Issued for Mannatech's Product Technology
COPPELL, Texas, Jan 11, 2011 (BUSINESS WIRE) -- Mannatech, Incorporated(NASDAQ: MTEX), a leading developer and provider of nutritional supplements and skin care products based on Real Food TechnologySM solutions, announced today the Australian Patent Office has granted the company a patent for technology related to its Ambrotose AO(R)product.
With the issuance of this new patent, Mannatech now holds 12 patents for technology related to Ambrotose AO in Australia, Mexico, New Zealand, Singapore, South Africa and South Korea.
"As a company based in scientific development, we consider our intellectual property to be one of our most valuable corporate assets," said Robert A. Sinnott, Ph.D., MNS, co-CEO and chief science officer of Mannatech. "Ambrotose AO technology has been granted patents consistently from governing bodies around the world; thus, validating the diligence and scientific research we put behind this important product for health and wellness."
Mannatech currently holds 63 patents in 30 countries for its health-related technologies.
Many of Mannatech's products are based on Real Food Technology solutions, which provide consumers with products that contain standardized levels of natural and plant-sourced nutrients. Food-sourced ingredients are chosen from those scientifically proven to most benefit the human body.
Individuals interested in Mannatech's products or in exploring its business opportunity can learn more at mannatech.com.
Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. These proprietary products are available through independent sales Associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore and the Republic of Korea. For more information, visit mannatech.com.
Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
SOURCE: Mannatech, Incorporated
for Mannatech, Incorporated
Allison Lowe Burum, 972-499-6631